Group 1 - The core point of the announcement is the renewal of the "Consistent Action Agreement" among the major shareholders of the company, which aims to ensure stable control and decision-making efficiency for the company's future development [1][2][4] Group 2 - The background of the renewal indicates that the original agreement was signed on December 25, 2019, and was set to expire on August 4, 2025. The agreement mandates that shareholders Zhou Yan and Zhou Fei must align their voting with Yang Yong's decisions [1][2] - The main content of the renewed agreement specifies that the consistent action period will now extend from August 5, 2025, to August 4, 2027, maintaining the requirement for unified voting [3] - The impact of the renewal confirms that there is no change in the company's controlling shareholders or actual controllers, which remains Yang Yong, Zhou Yan, and Zhou Fei. This stability is expected to benefit the company's strategic development and management policies [4]

Monetary Policy and Financial Support - The central bank will continue to implement a moderately loose monetary policy and promote rapid growth in loans to technology-oriented small and medium-sized enterprises, increasing financing support for key areas such as "two new" and "two heavy" [1] Taxation Changes - Starting from August 8, 2025, the Ministry of Finance and the State Taxation Administration will reinstate value-added tax on interest income from newly issued national bonds, local government bonds, and financial bonds [2] Infrastructure Development - Shanghai aims to establish at least five large-scale computing centers by the end of 2025, with a target computing power scale of over 100 EFLOPS (FP16) [3] Pharmaceutical Industry Insights - The Anhui Province centralized procurement platform has initiated market information collection for biological agents. Experts believe that the collective procurement of biological drugs cannot be directly compared to that of generic drugs, indicating significant flexibility in the pace of advancement and future price reductions [4] Company Performance - Shihua Machinery's independent director Zhou Jingping is under investigation [5] - Hikvision reported a year-on-year net profit increase of 11.71% in the first half of the year [5] - Ninebot Company achieved a net profit of 1.242 billion yuan in the first half of the year, a year-on-year increase of 108% [5] - BYD's automobile sales in July reached 344,296 units, a month-on-month decrease of 8.8% [5] - Luzhou Laojiao announced a dividend of 45.92 yuan per 10 shares for the 2024 fiscal year [5] - InnoCare responded to its collaboration with NVIDIA, stating that it is in the testing phase with no substantial orders yet [5]

近日，中微半导体（深圳）股份有限公司（以下简称"公司"）收到公司实 际控制人、控股股东杨勇、周彦、周飞续签《一致行动人协议》的通知，具体情 况如下： 一、本次续签《一致行动人协议》的背景情况 杨勇、周彦、周飞均为公司股东。杨勇、周彦别为公司第一、第二大股东， 周飞为周彦的弟弟。2019年 12 月 25 日，上述三人签署了《一致行动人协议》， 约定各方对于须由公司股东大会审议的事项，周彦、周飞应遵照杨勇的表决意见 行使股东表决权，即周彦、周飞应无条件确保其表决意见与杨勇保持一致，并约 定该《一致行动人协议》有效期自签订之日起至公司首次公开发行股票并合格 上市届满三年之日止。 证券代码：688380 证券简称：中微半导 公告编号：2025-025 中微半导体（深圳）股份有限公司 关于实际控制人续签一致行动人协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 中微半导体（深圳）股份有限公司董事会 2025 年 8 月 2 日 2 截至本公告披露日，杨勇、周彦、周飞分别持有公司股份数量 126,000,000 股、91, ...

证券代码：688380 证券简称：中微半导 中微半导体（深圳）股份有限公司 一、为确认出席大会的股东或其股东代理人或其他出席者的出席资格，会议工 作人员将对出席会议者的身份进行必要的核对工作，请被核对者给予配合。 二、为保证本次大会的严肃性和正常秩序，切实维护股东的合法权益，务必请 出席大会的股东或其股东代理人或其他出席者准时到达会场签到确认参会资格，在 会议主持人宣布现场出席会议的股东和股东代理人人数及所持有的表决权数量之 前，会议登记应当终止，在此之后进场的股东或股东代理人无权参与现场投票表决。 三、会议按照会议通知上所列顺序审议、表决议案。 四、股东及股东代理人参加股东大会依法享有发言权、质询权、表决权等权利。 股东及股东代理人参加股东大会应认真履行其法定义务，不得侵犯公司和其他股东 及股东代理人的合法权益，不得扰乱股东大会的正常秩序。 五、要求发言的股东及股东代理人，应提前在股东大会签到处进行登记，会议 进行中只接受股东及股东代理人发言或提问，股东现场提问请举手示意，经会议主 持人许可方可发言。有多名股东及股东代理人同时要求发言时，先举手者发言；不 能确定先后时，由主持人指定发言者。股东及股东代理人发 ...

证券代码：688380 证券简称：中微半导 中微半导体（深圳）股份有限公司 2025 年第一次临时股东大会会议资料 2025 年 8 月 7 日 目 录 | 2025年第一次临时股东大会会议须知 1 | | | --- | --- | | 2025年第一次临时股东大会会议议程 3 | | | 议案一：关于公司发行H股股票并在香港联合交易所有限公司上市的议案 5 | | | 议案二：关于公司发行H股股票并在香港联合交易所有限公司上市方案的议案 ... 6 | | | 议案三：关于公司申请转为境外募集股份有限公司的议案 | 10 | | 议案四：关于公司发行H股募集资金使用计划的议案 11 | | | 议案五：关于公司发行H股股票并在香港联合交易所有限公司上市决议有效期的议 | | | 案 | 12 | | 议案六：关于提请股东大会授权董事会及其授权人士全权办理公司发行H股并上市 | | | 相关事项的议案 | 13 | | 议案七：关于公司发行H股股票前滚存利润分配方案的议案 | 19 | | 议案八：关于公司聘请H股发行及上市的审计机构的议案 | 20 | | 议案九：关于修订公司部分制度的议案 | 21 | ...

中微半导最新一期业绩显示，截至2025一季报，公司营业总收入2.06亿元、同比增长0.52%，归属净利 润3442.02万元，同比增长19.40%，扣非净利润3258.01万元，同比增长31.75%，流动比率12.774、速动 比率11.282、资产负债率7.93%。 金融界消息 截至2025年7月30日收盘，中微半导（688380）报收于28.99元，上涨2.69%，换手率 8.11%，成交量11.98万手，成交金额3.43亿元。 资金流向方面，今日主力资金净流入2548.91万元，占比成交额7.44%。其中，超大单净流入1463.82万 元、占成交额4.27%，大单净流入1085.09万元、占成交额3.17%，中单净流出流出1795.80万元、占成交 额5.24%，小单净流出753.11万元、占成交额2.2%。 通过天眼查大数据分析，中微半导体(深圳)股份有限公司共对外投资了10家企业，参与招投标项目74 次，知识产权方面有商标信息6条，专利信息58条，此外企业还拥有行政许可12个。 来源：金融界 天眼查商业履历信息显示，中微半导体(深圳)股份有限公司，成立于2001年，位于深圳市，是一家以从 事软件和信 ...

Core Viewpoint - The announcement details the upcoming release of 21,285,000 restricted shares of Zhongwei Semiconductor (Shenzhen) Co., Ltd., which will become tradable on August 5, 2025, after a 36-month lock-up period following the company's initial public offering [1][4]. Summary by Sections 1. Listing of Restricted Shares - The total number of restricted shares to be listed is 21,285,000, representing 5.32% of the company's total share capital [1][4]. - The shares were initially issued at a price of 30.86 RMB each during the IPO, which took place on August 5, 2022 [1]. 2. Changes in Share Capital - Since the formation of the restricted shares, there have been no changes in the company's share capital [2]. 3. Commitments Regarding Restricted Shares - Shareholders holding restricted shares have committed not to transfer or manage these shares for 36 months from the date of listing [3]. - Any reduction in holdings must comply with relevant laws and regulations, with a maximum of 1% of total shares allowed to be sold in any 90-day period through centralized bidding, and 2% through block trading [3]. - If shares are transferred through agreement, the commitments will continue for six months following the transfer [3]. 4. Verification by Sponsor Institution - The sponsor institution has confirmed that the shareholders have adhered to the lock-up commitments, and the details regarding the release of restricted shares comply with applicable laws and regulations [4]. 5. Details of Restricted Shares - The listing of restricted shares is scheduled for August 5, 2025, with a total of 21,285,000 shares to be released [4][6]. - The shareholders include various investment firms, and the lock-up period for certain shareholders has been extended by an additional six months [5].

证券代码：688380 证券简称：中微半导 公告编号：2025-024 本次股票上市流通总数为21,285,000股。 本次股票上市流通日期为2025 年 8 月 5 日。 中微半导体（深圳）股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 21,285,000股。本公司确认，上市流通数量小于该限售期的全部限售股份数量。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会《关于同意中微半导体（深圳）股份有限公司 首次公开发行股票注册的批复》（证监许可〔2022〕910 号），同意公司首次公开发 行股票的注册申请。公司获准向社会公开发行人民币普通股 63,000,000 股，每股 发行价格为 30.86 元，并于 2022 年 8 月 5 日在上海证券交易所科创板挂牌上市， 发行完成后总股本为 400,365,000 股，其中有限售条件流通股为 346,424,749 股， 占公司总股本的 8 ...

中信证券股份有限公司 关于中微半导体（深圳）股份有限公司 首次公开发行部分限售股上市流通的核查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐人"）作为中微半 导体（深圳）股份有限公司（以下简称"公司"、"中微半导"或"发行人"）首 次公开发行股票并在科创板上市的保荐人。根据《中华人民共和国公司法》《中 华人民共和国证券法》《上海证券交易所科创板股票上市规则》等有关规定，对 公司首次公开发行部分限售股上市流通的事项进行了核查，核查情况如下： 一、本次上市流通的限售股类型 根据中国证券监督管理委员会《关于同意中微半导体（深圳）股份有限公司 首次公开发行股票注册的批复》（证监许可〔2022〕910 号），同意公司首次公开 发行股票的注册申请。公司获准向社会公开发行人民币普通股 63,000,000 股，每 股发行价格为 30.86 元，并于 2022 年 8 月 5 日在上海证券交易所科创板挂牌上 市，发行完成后总股本为 400,365,000 股，其中有限售条件流通股为 346,424,749 股，占公司总股本的 86.53%；无限售条件流通股为 53,940,251 股，占公司总股 本的 13.47% ...

Market Performance - A-shares experienced a slight increase, with the Shanghai Composite Index up 0.01% to 3582.3 points, while the Shenzhen Component fell by 0.37%[1] - The Hong Kong Hang Seng Index closed up 1.62% at 25538.07 points, with the Hang Seng Tech Index rising 2.48% and the Hang Seng China Enterprises Index increasing by 1.82%[1] - The total trading volume in Hong Kong surged to 3330.666 million HKD[1] Trade and Tariff Developments - Trump indicated that the reciprocal tariff rates would range from 15% to 50%, with most EU products expected to have a tariff rate set at 15%[1][15] - The EU and the US are reportedly moving towards a trade agreement, with a proposed 15% tariff on most products[15] Corporate Earnings and Forecasts - Tesla reported a 12% decline in revenue to 22.5 billion USD, marking the largest quarterly drop in at least a decade, with adjusted earnings per share at 0.40 USD, slightly below analyst expectations[15] - Tesla's gross margin remains above average expectations, indicating resilience in profitability despite revenue challenges[15] International Relations - Xi Jinping is scheduled to meet with EU leaders in Beijing, with discussions expected to focus on climate cooperation, although no joint statement is planned[15] - The meeting highlights ongoing tensions and divisions between China and the EU, despite previous signs of thawing relations[15]